Barry I. Hudson

5.6k total citations · 1 hit paper
65 papers, 4.5k citations indexed

About

Barry I. Hudson is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Barry I. Hudson has authored 65 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Clinical Biochemistry, 23 papers in Molecular Biology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Barry I. Hudson's work include Advanced Glycation End Products research (43 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and S100 Proteins and Annexins (14 papers). Barry I. Hudson is often cited by papers focused on Advanced Glycation End Products research (43 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and S100 Proteins and Annexins (14 papers). Barry I. Hudson collaborates with scholars based in United States, United Kingdom and Sweden. Barry I. Hudson's co-authors include Ann Marie Schmidt, Marc E. Lippman, Anastasia Z. Kalea, Peter J. Grant, Max H. Stickland, Evis Harja, Vivette D. D’Agati, Shi Fang Yan, Éric Boulanger and T. Simon Futers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Barry I. Hudson

61 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting RAGE Signaling in Inflammatory Disease

2017 395 citations Barry I. Hudson, Marc E. Lippman profile →

Peers

Countries citing papers authored by Barry I. Hudson

Since Specialization

Citations

This map shows the geographic impact of Barry I. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry I. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry I. Hudson more than expected).

Fields of papers citing papers by Barry I. Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry I. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry I. Hudson. The network helps show where Barry I. Hudson may publish in the future.

Co-authorship network of co-authors of Barry I. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Barry I. Hudson. A scholar is included among the top collaborators of Barry I. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry I. Hudson. Barry I. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A low-glucose eating pattern is associated with improvements in glycemic variability among women at risk for postmenopausal breast cancer: an exploratory analysis 2024 ·Frontiers in Nutrition ·Michelle R Jospe, Yue Liao, Erin D. Giles, Barry I. Hudson, Joyce M. Slingerland, Susan M. Schembre	0
2	RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer 2023 ·npj Breast Cancer ·Melinda Magna, (unknown), (unknown), Katherine Drews‐Elger, Masaru Takabatake, (unknown), (unknown), Taekyoung Kwak, Philip Miller, Marc E. Lippman, Barry I. Hudson	24
3	Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast Cancer 2022 ·Psychosomatic Medicine ·Chloe J. Taub, Alain Diaz, Bonnie B. Blomberg, Devika R. Jutagir, Hannah M. Fisher, Lisa M. Gudenkauf, Marc E. Lippman, Barry I. Hudson, Michael H. Antoni	5
4	Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: Results from the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth) 2017 ·Journal of Diabetes and its Complications ·Christina M. Parrinello, Simin Hua, Mercedes R. Carnethon, Linda C. Gallo, Barry I. Hudson, Ronald Goldberg, Alan M. Delamater, Robert C. Kaplan, Carmen R. Isasi	7
5	Phagocyte–myocyte interactions and consequences during hypoxic wound healing 2014 ·Cellular Immunology ·Shuang Zhang, Shirley Dehn, Matthew DeBerge, Ki‐Jong Rhee, Barry I. Hudson, Edward B. Thorp	14
6	Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function 2013 ·PLoS ONE ·Joel Jules, Dony Maiguel, Barry I. Hudson	46
7	RAGE binds C1q and enhances C1q-mediated phagocytosis 2012 ·Cellular Immunology ·Wanchao Ma, Vivek Rai, Barry I. Hudson, Fei Song, Ann Marie Schmidt, Gaetano R. Barile	56
8	Serum Adiponectin in Relation to Race–Ethnicity and Vascular Risk Factors in the Northern Manhattan Study 2012 ·Metabolic Syndrome and Related Disorders ·Hannah Gardener, Milita Crisby, (unknown), Barry I. Hudson, Ronald Goldberg, Armando J. Mendez, Clinton B. Wright, Tatjana Rundek, Mitchell S.V. Elkind, Ralph L. Sacco	28
9	Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling 2010 ·Cancer Research ·Anastasia Z. Kalea, Fiona See, Evis Harja, Maria Arriero, Ann Marie Schmidt, Barry I. Hudson	36
10	Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells 2010 ·Atherosclerosis ·Andreas Pollreisz, Barry I. Hudson, Jong Sun Chang, Wu Qu, Bin Cheng, Panos N. Papapanou, Ann Marie Schmidt, Evanthia Lalla	37
11	Kansuinine A and Kansuinine B fromEuphorbia kansuiL. Inhibit IL-6-induced Stat3 Activation 2010 ·Planta Medica ·Jong Hee Chang, Seung Woong Lee, Mi Ae Park, (unknown), Barry I. Hudson, Su-Jin Park, Woo Jung Lee, Mun‐Chual Rho	14
12	Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases 2009 ·Lara D. Veeken ·H. Maillard-Lefebvre, Éric Boulanger, Maïté Daroux, Cédric Gaxatte, Barry I. Hudson, M. Lambert	154
13	The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study 2005 ·Atherosclerosis ·M. Hofmann, Qiong Yang, Evis Harja, Prashant Kedia, Peter K. Gregersen, L. Adrienne Cupples, Ann Marie Schmidt, Barry I. Hudson	35
14	Receptor for Advanced Glycation End Products and Its Ligands: A Journey from the Complications of Diabetes to Its Pathogenesis 2005 ·Annals of the New York Academy of Sciences ·William Kim, Barry I. Hudson, Bernhard Moser, Jiancheng Guo, Ling Rong, Yan Lü, Wu Qu, Evanthia Lalla, Shulamit Lerner, (unknown), Shirley Shi Du Yan, Vivette D. D’Agati, Yoshifumi Naka, Ravichandran Ramasamy, Kevan C. Herold, Shi Fang Yan, Ann Marie Schmidt	80
15	RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease 2004 ·Pharmaceutical Research ·Barry I. Hudson, Ann Marie Schmidt	64
16	Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders 2003 ·Archives of Biochemistry and Biophysics ·Barry I. Hudson, Loredana Bucciarelli, Thoralf Wendt, Taichi Sakaguchi, Evanthia Lalla, Wu Qu, Yan Lü, (unknown), David M. Stern, Yoshifumi Naka, Ravichandran Ramasamy, Shi Du Yan, Shi Fang Yan, Vivette D. D’Agati, Ann Marie Schmidt	141
17	Glucose, Glycation, and RAGE 2003 ·Journal of the American Society of Nephrology ·Thoralf Wendt, Nozomu Tanji, Jiancheng Guo, Barry I. Hudson, Angelika Bierhaus, Ravichandran Ramasamy, Bernd Arnold, Peter P. Nawroth, Shi Fang Yan, Vivette D. D’Agati, Ann Marie Schmidt	203
18	Glycation and diabetes: The RAGE connection 2002 ·Current Science ·Barry I. Hudson, M. Hofmann, Loredana Bucciarelli, Thoralf Wendt, Bernhard Moser, Yan Lü, Wu Qu, David M. Stern, Vivette D. D’Agati, Shirley ShiDu Yan, Shi Fang Yan, Peter J. Grant, Ann Marie Schmidt	41
19	RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response 2002 ·Genes and Immunity ·M. Hofmann, (unknown), Barry I. Hudson, (unknown), W. Qu, Yan Lü, Evanthia Lalla, Saurabh Deepak Chitnis, J Monteiro, Max H. Stickland, Loredana Bucciarelli, Bernhard Moser, George Moxley, Silviu Itescu, Peter J. Grant, Peter K. Gregersen, D Stern, Ann Marie Schmidt	321
20	STUDIES ON RAT TESTICULAR CELLS IN TISSUE CULTURE 1971 ·Reproduction ·D. M. de Kretser, K. J. Catt, Maria Dufau, Barry I. Hudson	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact